Rocbrutinib Clinical Trials
4 recruitingDrug
Phase 32Phase 21Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 3
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
CLLCLL/SLLCLL (Chronic Lymphocytic Leukemia)+5 more
Newave Pharmaceutical Inc306 enrolled4 locationsNCT07342478
Recruiting
Phase 3
A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.394 enrolled2 locationsNCT07377578
Recruiting
Phase 2
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD.150 enrolled41 locationsNCT07189065
Recruiting
Phase 1
Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma
B-cell Non Hodgkin Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.112 enrolled1 locationNCT06251180